Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Farnesoid-X-receptor antagonist as a vaccine adjuvant

Farnesoid-X-receptor antagonist as a vaccine adjuvant

US Patent 8647643 · Granted Feb 11, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic cancer vaccine2022
Therapeutic cancer vaccine2022
Synthesis of novel intermediate(s) for preparing rivastigmine2021
Synthesis of novel intermediate(s) for preparing rivastigmine2021
Therapeutic cancer vaccine2019
Therapeutic cancer vaccine2019
Pharmaceutical composition of killed cells with substantially retained immunogen2017
Pharmaceutical composition of killed cells with substantially retained immunogen2017
Stable pharmaceutical composition for atherosclerosis2017
Stable pharmaceutical composition for atherosclerosis2017
Stable pharmaceutical composition for atherosclerosis2017
Cancer antigen2017